Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests High-Tech glucose monitor for diabetes patients leaving hospital

NCT ID NCT07414277

First seen Feb 21, 2026

Summary

This study looks at whether using a continuous glucose monitor (CGM) helps people with type 2 diabetes who take insulin keep their blood sugar under control after they leave the hospital. About 160 adults will either use a CGM or do standard finger-prick tests for 12 weeks. The goal is to see if the CGM leads to better blood sugar levels and fewer highs and lows.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai 6th People's Hospital

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai 7th People's Hospital

    Shanghai, 200137, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai Fengxian District Central Hospital

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai General Hospital

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.